Research Advance of Microparticles in Hypercoagulation of Hemolytic Anemia-Review.
10.7534/j.issn.1009-2137.2017.02.058
- VernacularTitle:微粒与溶血性贫血高凝状态的研究进展
- Author:
Xie SU
1
;
Peng CHENG
2
;
Dong-Hong DENG
1
Author Information
1. Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
2. Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.E-mail:gxchengpeng@163.com.
- Publication Type:Journal Article
- From:
Journal of Experimental Hematology
2017;25(2):622-626
- CountryChina
- Language:Chinese
-
Abstract:
Microparticles (MP) are small membrane vesicles released from many different cell types in response to cellular activation or apoptosis, which have the procoagulant effect. Hemolytic anemia(HA) is a type of anemia that have a short life expectancy of red blood cells due to the destruction which exceed the hematopoietic compensatory capacity of bone marrow. Sickle cell anemia(SCD), thalassemia and paroxysmal nocturnal hemoglobinuria(PNH) are all characterized by hypercoagulation and thromboembolism (TE). Research shows that MP can promote the formation of hypercoagulative state which in turn increases the risk of thromboembolism in HA. This review mainly summarized the advance research of MP in HA in the past 5 years. Moreover the relationship between the abnormal MP and hypercoagulation in HA, the impact of the related treatment to the MP, the research of MP in animal model of HA and the application of the MP-proteomics in HA are also disscussed.
